Long‐Term Local Control and Mortality After Transpupillary Thermotherapy of Small Uveal Melanomas
Clinical & Experimental Ophthalmology · 2026
DOI: 10.1111/ceo.70126 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical & Experimental Ophthalmology, 2026. Verfasst von Maria Fili und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Neuroscience, Division of Eye and Vision, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Melanoma, Hyperthermia, Induced, Uveal Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: St. Erik Eye Hospital, S:t Eriks Ögonforskningsstiftelse.
Abstract (Originalsprache)
Background
Transpupillary thermotherapy (TTT) is used for selected small choroidal melanocytic tumours, either as primary treatment or as an adjunct to plaque brachytherapy. We compared long‐term local recurrence and mortality outcomes after primary TTT alone, plaque brachytherapy combined with TTT (brachy+TTT), and plaque brachytherapy alone (brachy alone).
Methods
This retrospective cohort study included 850 patients with choroidal melanocytic tumours treated with eye‐preserving modalities at St. Erik Eye Hospital, Stockholm, Sweden, 2008–2020. Primary treatment was TTT alone ( n = 48), brachy+TTT ( n = 105), or brachy alone ( n = 697). Outcomes included local recurrence, local recurrence with extraocular extension (EXE), and mortality.
Results
At 15 years, Kaplan–Meier local recurrence‐free survival was 8% after TTT alone, 34% after brachy+TTT, and 86% after brachy alone (log‐rank test for trend, p < 0.001). Disease‐specific survival at 15 years was 46%, 85%, and 90%, respectively ( p = 0.03). In multivariable Fine–Gray regression adjusting for American Joint Committee on Cancer stage, TTT alone was associated with a higher subdistribution hazard of local recurrence (sHR, 6.7; p < 0.001) and melanoma‐related death (sHR, 3.9; p < 0.001). Among patients treated for local recurrence, subsequent recurrences occurred more frequently after TTT than after treatments involving brachytherapy. The risk of EXE increased with the number of TTT sessions.
Conclusions
In this single‐centre retrospective cohort, TTT was associated with higher rates of local recurrence and melanoma‐related mortality compared with plaque brachytherapy. Future studies should assess whether similar results are observed in external long‐term cohorts; such findings would inform whether the role of TTT in the management of choroidal melanocytic tumours warrants reconsideration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Neuroscience, Division of Eye and Vision, Karolinska Institutet, Stockholm, Sweden.
- Ocular Oncology Service, St. Erik Eye Hospital, Stockholm, Sweden.
- St. Erik Ophthalmic Pathology Laboratory, St. Erik Eye Hospital, Stockholm, Sweden.
ORCID-Profile: Gustav Stålhammar
Förderung
- St. Erik Eye Hospital
- S:t Eriks Ögonforskningsstiftelse
Zitieren
APA
Fili, M., Ermedahl Conradi, M., Klaff Dahl, M., Sabazade, S., Casselholm De Salles, M., & Stålhammar, G. (2026). Long‐Term Local Control and Mortality After Transpupillary Thermotherapy of Small Uveal Melanomas. Clinical & Experimental Ophthalmology. https://doi.org/10.1111/ceo.70126
Vancouver
Fili M, Ermedahl Conradi M, Klaff Dahl M, Sabazade S, Casselholm De Salles M, Stålhammar G. Long‐Term Local Control and Mortality After Transpupillary Thermotherapy of Small Uveal Melanomas. Clinical & Experimental Ophthalmology. 2026. doi:10.1111/ceo.70126
BibTeX
@article{Fili2026,
author = {Fili, Maria and Ermedahl Conradi, Malin and Klaff Dahl, Maya and Sabazade, Shiva and Casselholm De Salles, Manuel and Stålhammar, Gustav},
title = {Long‐Term Local Control and Mortality After Transpupillary Thermotherapy of Small Uveal Melanomas},
journal = {Clinical & Experimental Ophthalmology},
year = {2026},
doi = {10.1111/ceo.70126}
}
EUVIMED